News

COST presentation at the Graphene week

Submitted by Prof Sabrina Pricl on Wed, 18/09/2019 - 21:42

We are happy to let you know that COST will be present at the Graphene Week organized by the Graphene flagship.  COST will be present in the exhibition area (stand 09-1st floor) and give the presentation at the fringe session on 25th 14:30-15:30.
For your information, COST has highlighted our Action as potentially of interest for the participants of this event and it will be promoted in the Graphene Week Conference leaflet.
 
Please be so kind to inform all interested colleagues and feel free to come and visit COST if you are at the event!

Colloidal Nanoparticles for Biomedical Applications XV

Submitted by Prof Sabrina Pricl on Wed, 07/08/2019 - 09:20

Dear COSTers,

please find below the information on the folllowing upcoming Conference advertised by our member Antonios Kanaras:

Colloidal Nanoparticles for Biomedical Applications X

More info can be found at the Conference website: https://spie.org/PWB/conferencedetails/colloidal-nanoparticles-biomedical-applications

The abstract deadline has been extended till August 20.

Conference Detail for Colloidal Nanoparticles for Biomedical Applications XV - SPIE - the international society for optics and photonics

spie.org

Ongoing rapid progress in the synthesis of a variety of biofunctionalized colloidal nanoparticles with fascinating electronic, magnetic, and optical properties not associated with bulk materials symbolizes a fundamental breakthrough in physics and chemistry of condensed matter, which significantly extends our knowledge about the nature of materials and our abilities to manipulate their properties.

1st CA17140 Conference: Abstract submission deadline postponed to July 26

Submitted by Prof Sabrina Pricl on Mon, 22/07/2019 - 08:49

Dear COSTers,

although so far we have rceived more than 50 abstracts for our 1st CA17140 Conference in Riga, we decided to extend the deadline for abstract submission to July 26, 2019.

Aftr that date, the Scient6ific Committe will start the abstract selection process for the assignemnt of the fully supported oral communications.

More details about the event and the abstract template can be found here.

Please do send your abstract and contribute to the success of our Action!

Marie Skłodowska-Curie (MSC) Individual Fellowship awarded to Dr. Evgeny K. Apartsin

Submitted by Prof Sabrina Pricl on Sun, 14/07/2019 - 09:25

Dear COSTers,

it is a pleasure to announce that our CA17140 member fro m Russia, Dr. Evgeny K. Apartsin, has been awarded the MSC Individual fellowship with the project "Design of multifunctional phosphorous dendritic systems for drug delivery" — EUREKA (grant No. 844217).

Dr. Apartsin will carry out the scientific activity of his MSC project in France, at the Laboratoire de Chimie de Coordination of the CNRS in Toulouse, France, in collaboration with Prof. Jean-Pierre Majoral and Prof. Anne-Marie Caminade.

The abstrct of Dr. Apartsin's project is reported below.

The whole CA17140 community congratulates Dr. Apartsin on his great achievement!

Dr. Apartsin's MSC Project abstract:

The aim of the project is to provide the interdisciplinary training to young talented researcher Dr. Evgeny Apartsin, specialist in biomaterials science and nucleic acid therapy, to become highly qualified world class researcher. The Applicant proposes an interdisciplinary approach for the design of multifunctional phosphorous dendritic systems for the delivery of therapeutic nucleic acids in vitro and in vivo. During the project implementation, novel stimuli-sensitive supramolecular constructions based on phosphorous dendrimers and dendrons will be created to be used as carriers for chemodrugs and nucleic acids. The synthetic part of work will be done in the Host organization, which is world leading institution in the dendrimer science and applications. The physics-chemical and biological parts will be done in collaboration with the Partner organization together with recognized specialists in biophysics, molecular and cell biology. At the last stage of the project, the synthesis of best candidate therapeutic constructions will be transferred to the industry. The Applicant will receive numerous scientific trainings from the experts in macromolecules and medicinal chemistry, molecular biology and industrial technology as well as additional trainings on project management and funding, public dissemination of results, presenting and teaching. The trainings and the implementation of this project (knowledge, skills, papers, patents, etc.) will help the Applicant to be efficiently integrated into the European and international science at highest level.

 

European Cooperation in Science and Technology (COST) logo
EU flag logo

Funded by the Horizon 2020 Framework Programme
of the European Union